Three-Strain Probiotic Combo Repairs Leaky Gut in Undernourished Adults, Trial Finds

Undernutrition does more than strip away muscle and fat. It quietly dismantles the intestinal wall, letting bacterial toxins seep into the bloodstream and triggering a cycle of oxidative stress and inflammation that extra calories alone cannot reverse. A randomized controlled trial published June 2026 by Ahmadi-Khorram and colleagues suggests that an eight-week course of a three-strain probiotic combination, layered on top of a calorie-surplus diet, may help break that cycle in underweight adults.

Zonulin, antioxidant capacity, and CRP all shifted in the probiotic group

The trial's headline numbers are hard to dismiss. Serum zonulin, a protein that regulates the tight junctions holding the gut lining together and therefore a direct marker of intestinal permeability, fell by 0.98 ng/mL on average in the probiotic group over eight weeks, compared with just 0.22 ng/mL in the placebo group (p = 0.047). That gap suggests the probiotic regimen was doing something beyond the caloric top-up both groups received.

The oxidative stress picture shifted just as sharply. Total antioxidant capacity climbed by +0.40 mmol/L in the probiotic arm while barely budging in the placebo arm (-0.01 mmol/L; p < 0.001). Total oxidant status moved in the opposite, desirable direction: down 4.22 micromol/L in the probiotic group versus up 0.79 micromol/L in controls. The antioxidant enzyme glutathione peroxidase increased by 4.0 nmol/mL while malondialdehyde, a marker of lipid damage, decreased by 0.046 nmol/mL. On the inflammatory side, C-reactive protein dropped by 0.50 mg/L in treated participants while ticking up by 0.10 mg/L in the placebo group, and the one-hour erythrocyte sedimentation rate followed the same pattern.

Undernourished adults face compounding gut damage that goes beyond calorie deficits

To appreciate why these findings matter, it helps to understand what undernutrition does to the gut lining. Research on undernutrition and intestinal infections shows that a compromised gastrointestinal mucosa aggravates chronic subclinical enteric dysfunction, raises susceptibility to infection, and sustains a feed-forward loop of inflammation. Separately, work on pediatric intestinal health and undernutrition documents villi atrophy, goblet cell loss, and a thinned mucus layer as characteristic consequences of inadequate nutrition, all of which increase barrier leakiness.

Adults with a body mass index below 18.5 kg/m² face the same underlying physiology. A 500-calorie daily surplus can promote weight gain but does not directly restore tight junction integrity or quench the oxidant load that accumulates when the barrier is compromised. That is precisely the gap these researchers aimed to fill with probiotics.

How the trial was designed and who it enrolled

The double-blind, placebo-controlled study enrolled 100 underweight adults aged 18 to 60 years and randomized them equally using sex-stratified block randomization. Both groups followed a 500 kcal/day energy-surplus diet throughout the eight weeks. The probiotic group received two capsules daily, each containing Lactobacillus acidophilus LA5, Lactobacillus rhamnosus GG, and Lactobacillus casei, with each strain dosed at 10^9 colony-forming units per capsule. Placebo capsules were visually identical. Ninety-five participants completed the trial and were included in the per-protocol analysis.

Zonulin served as the pre-specified primary outcome because it offers a blood-based readout of gut permeability without requiring the sugar probe tests (such as lactulose-mannitol ratios) described in older intestinal permeability methodology. Secondary outcomes covered the full panel of oxidative stress and inflammatory markers described above, and all showed statistically significant between-group differences.

The biological rationale for why this combination might work is supported by mechanistic reviews showing that probiotics strengthen the intestinal barrier by upregulating tight junction proteins and mucin production, reducing endotoxin translocation, and suppressing the NF-kB inflammatory pathway. These are plausible mechanisms for the zonulin and CRP changes observed in the trial.

Caveats: eight weeks, one population, no microbiome data

The results are encouraging but several limitations deserve attention. The trial ran for only eight weeks in a single geographic population, so it is unknown whether the benefits persist longer term or generalize to undernourished people in different settings. The study measured systemic biomarkers but did not characterize the gut microbiome directly, leaving open the question of which microbial shifts, if any, drove the observed changes in permeability and redox balance.

Sample size is also a consideration: 95 completers is large enough to detect the reported effects with statistical confidence, but the field still lacks the kind of large, multi-site confirmatory studies that would cement clinical guidance. A review of probiotic and prebiotic research in undernourished individuals has flagged exactly this gap, noting that robust, well-designed human trials with defined primary outcomes are critical before efficacy can be confidently claimed.

What comes next for probiotics in clinical nutrition

If the findings replicate, the practical implication is relatively straightforward: when clinicians or nutritionists design refeeding protocols for underweight adults, a multi-strain probiotic may be worth adding alongside the caloric intervention rather than treating nutrition rehabilitation as a single-variable problem. The specific strains used here, LA5, GG, and casei, are commercially available and well-characterized for safety, which lowers the barrier to testing this approach in other settings.

Longer trials tracking weight-gain outcomes alongside the biomarkers measured here would strengthen the case. It is also worth noting that a meta-analysis on probiotic supplementation for growth in undernourished children found little effect on anthropometric measures, suggesting that improving gut barrier function may not automatically translate into faster weight recovery. Understanding whether the biological improvements seen in this trial eventually support better nutritional outcomes is perhaps the most important question the next wave of research needs to answer.

Evidence rating

EMERGING — 84/100

Caveats:

• Single trial conducted in a specific population (underweight adults, BMI < 18.5); findings may not generalize to healthy-weight or obese individuals.
• Modest sample size (n=95 per-protocol) limits statistical power for subgroup effects and long-term conclusions.
• The zonulin effect size was relatively small (p=0.047), and zonulin assays have known cross-reactivity limitations as a gut permeability biomarker.
• Funding source was not disclosed; independent replication has not yet occurred.
• Both groups received a calorie-surplus diet, making it difficult to fully isolate the probiotic effect from nutritional rehabilitation alone.

Double-blind, placebo-controlled RCT (n=95 per-protocol) conducted over 8 weeks in underweight adults. Demonstrates statistically significant between-group improvements in gut permeability, oxidative stress, and inflammation markers, but the primary outcome (zonulin) reached only marginal significance (p=0.047) and the study has not yet been independently replicated. Association between the probiotic regimen and outcomes is well-characterized, though the causal pathway from microbial activity to systemic inflammation reduction is partially rather than fully elucidated.